The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization.
about
Roles and relevance of mast cells in infection and vaccinationNew era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant developmentTLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN RoutesSublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.Activities of stromal and immune cells in HPV-related cancers.
P2860
The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@en
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@nl
type
label
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@en
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@nl
prefLabel
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@en
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@nl
P2093
P2860
P356
P1433
P1476
The immune complex CTA1-DD/IgG ...... nity after nasal immunization.
@en
P2093
P2860
P2888
P304
P356
10.1038/MI.2013.16
P577
2013-04-10T00:00:00Z
P5875
P6179
1040696986